Omeoformula 4 Breast
Generic name: adenosine triphosphate, aconitic acid, cis-, sus scrofa embryo, sus scrofa pituitary gland, magnesium phosphate, sus scrofa mamma, nadide, senecio vulgaris, pulsatilla vulgaris, sus scrofa skin and sus scrofa uterus
Dosage form: injection, solution
Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Drug Abuse and Dependence
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- Patient Counseling Information
1. INDICATIONS AND USAGE
1.1. Breast tissue revitalisation
1.2. Breast Firming.
2. DOSAGE AND ADMINISTRATION
2.1. Treatment for IM application: 1 vial 1-3 times a week according to severity and clinic evolution.
2.2. Treatment using mesotherapy technique: Apply 0,3 ml for each point. Using a 13 mm, 30G or a 4 mm, 27G needle, make the classic intradermal injections utilizing mesotherapy technique.
Sites of application: Tissue area around the breast, without injecting the mammal gland.
- From the clavicle, go down along the pectoral muscle with 3 parallel injection lines.
- From the areola, proceed with 4 injection lines, in a sunburst shape.
- In the space below the breast, along its insertion on the thorax.
Standard protocol consists of one treatment a week for 5-7 weeks. For prolonged treatments, 2 treatments for the first week, 1 treatment a week for 1 month and then 1 treatment a month are recommended.
Discard unused solution.
2.3. Opening of Vials: Use sterile needles and sterile syringe. Do not reuse. Do not use if foreign particles are present. Draw 1 cc of air into syringe, insert needle into vial inject air and withdraw the solution into the syringe.
3. DOSAGE FORMS AND STRENGTHS
3.1. Injectable solution for subcutaneneous, intradermal or intramuscular administration.
Pharmaceutical forms: 2 ml glass vials
3.2. Each ingredient is attenuated according to the procedures stated in the Homeopathic Pharmacopeia of United States.
Active ingredients: Adenosintriphosphate 10X; Cis-Aconitic